Overview

Single-Dose, Crossover Study To Compare Bioavailability Of Two Formulations Under Fed And Fasted Conditions

Status:
Completed
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
To Compare The Bioavailability Of 40 Mg Doses Of Pf-00345439 Modified Formulation K Vs. Original Formulation X Under Fed And Fasting Conditions In Healthy Volunteers
Phase:
Phase 1
Details
Lead Sponsor:
Pain Therapeutics
Treatments:
Oxycodone